Abstract

Abstract Natural killer (NK) cells are involved in tumor immune surveillance, immunity to infection, and various pathological conditions. One mode of NK cell recognition, ‘missing-self’ recognition, is triggered by downregulation of inhibitory self ligands on target cells, thereby decreasing the net signaling threshold to promote NK cell activation. Clr-b, ligand for the NKR-P1B inhibitory NK receptor, is downregulated during cellular transformation, viral infection, and genotoxic stress, in turn promoting MHC-independent missing-self recognition. However, the mechanisms underlying the loss of Clr-b during oncogenic transformation remain unknown. Here, we demonstrate that proto-oncogene, Ras, is directly involved in Clr-b downregulation on mouse fibroblasts via the Raf/MEK/ERK and PI3K pathways. We show that c-myc overexpression also promotes Clr-b downregulation. To examine a link between the loss of Clr-b and tumour progression using a spontaneous B cell lymphoma model, we backcrossed the Emu-c-myc transgene onto a Clr-b−/− background, then assessed the survival rates of transgenic littermates. Preliminary results reveal a trend towards accelerated tumor progression of Clr-b+/+ littermates versus Clr-b+/− littermates, suggesting a potential protective role for Clr-b loss in tumour immune surveillance, one revealed under loss-of-heterozygosity conditions. Notably, previous results using Nkrp1b−/− mice also suggest that NKR-P1B-mediated inhibition may also facilitate deleterious tumour immune escape. Collectively, our data suggest that Clr-b downregulation during oncogenic transformation plays a role in the detection of oncogenic transformation and cancer immunosurveillance by NK cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.